Lower-Than-Expected Inflation and Potential Trump-Xi Trade Deal Boost S&P 500
The S&P 500 (Index: SPX) clocked another record high for 2025, rising 1.9% over its previous week’s close to 6,791.69 at the end of trading on Friday, 24 October 2025.
With the fourth quarter’s earnings season under way, good earnings reports and optimism about the prospects for future earnings helped solidify stock prices early in the week. On Friday however, stock prices rose as investors absorbed two new pieces of information.
The first of those two new pieces of information was the shutdown-delayed release of the Consumer Price Index, which confirmed inflation during September 2025 had come in slightly lower than had been expected. That was significant because it clears the way for the Federal Reserve to continue cutting the Federal Funds Rate.
The CME Group’s FedWatch Tool forecasts the Fed’s next action will be to reduce this rate by a quarter point on Wednesday, 29 October (2025-Q4). Looking beyond that date, the FedWatch tool predicts the Fed will deliver another quarter point when it next meets to set rates on 10 December (2025-Q4).
The second new piece of information was the confirmation U.S. President Donald Trump would meet with China’s President Xi Jinping to potentially unveil a new trade deal between the two nations at the Association of South East Asian Nations (ASEAN) summit within the next several days, which added a speculative boost to the S&P 500 because it prompted investors to shift their time horizon from 2026-Q2 to 2025-Q4.
That shift can be seen in the latest update of the alternative futures chart, which visualizes the potential trajectories the S&P 500 may take depending upon how far into the future investors are focusing their forward-looking attention.
Next week could see more stock price movement related to news of trade deals made at the ASEAN summit. Until then, here are the market moving headlines that shaped investors’ future expectations during the trading week ending on 24 October 2025:
- Monday, 20 October 2025
-
- Signs and portents for the U.S. economy:
- Trump approves expanding credits for US auto production, issues new 25% truck duties
- China imports no US soybeans in September for first time in seven years
- Oil prices slip on concerns over a supply glut
- US regional banks’ earnings under scrutiny with jitters over credit risks
- Investor behind Zions, Western Alliance bad loans is tied to $270 million in troubled debt
- US bank rout prompts deal speculation as credit worries loom
- US bets on Australian miners to break China’s grip on critical minerals supply
- Bigger trouble, stimulus developing in China:
- Fall in China’s exports of rare earth magnets stokes supply chain fears
- China’s new home prices fall at fastest pace in 11 months
- BOJ minions trying to be mysterious about what they’re going to do for some reason:
- Bank of Japan’s Ueda keeps cards close to chest ahead of October meeting
- Hawkish BOJ board member keeps up calls for more rate hikes
- BOJ may slightly revise up this year’s growth forecast, sources say
- Wall Street ended higher ahead of a busy earnings week and inflation data
- Tuesday, 21 October 2025
-
- Signs and portents for the U.S. economy:
- Fed minions expected to deliver two more rate cuts before end of 2025:
- US Fed to trim rates twice more this year; 2026 rate path very unclear
- Waller says Fed staff studying streamlined ‘payment accounts’
- Bigger trouble, stimulus developing in China:
- Foreign Investors Trapped in China’s Real Estate Meltdown as $140 Billion Bet Unravels Further
- China’s consumer subsidy scheme needs a rethink
- BOJ minions get new big boss who wants to see wage-price inflation:
- Japan’s Takaichi calls on BOJ to pursue inflation driven by wage gains
- Japan’s next finance minister could unsettle yen bears
- ECB minions worrying about US dollar:
- Wall Street closed mixed as traders digested a wave of earnings data
- Wednesday, 22 October 2025
-
- Signs and portents for the U.S. economy:
- Oil rises about 2% on higher US demand, trade talk optimism
- Exclusive: US considering curbs on exports to China made with US software, sources say
- India nears deal to slash US tariffs on Indian imports to 15%-16%, Mint reports
- Fed minions thinking big banks may not need to stash so much capital:
- US Fed floats plan with smaller capital hikes for big banks, Bloomberg News reports
- US banks’ surge in loans to private creditors may pose risks, Moody’s says
- BOJ minions expected to hike Japan’s interest rates as Japan’s export economy shows recovery signs:
- BOJ poised to hike interest rates in Q4, majority of economists say
- Japan’s exports snap four-month slump as weak yen offsets US tariff hit
- ECB minions / Bigger trouble developing in Eurozone:
- Nasdaq slumps more than 1% as Netflix’s plunge drags Wall Street lower
- Wall Street ends lower on mixed earnings, revived US-China trade tensions
- Thursday, 23 October 2025
-
- Signs and portents for the U.S. economy:
- Exclusive: China state oil majors suspend Russian oil buys due to sanctions
- Russia, at war, faces double trouble: Trump ultimatum and a hit to oil sales to India
- China, U.S. to hold trade talks in Malaysia as truce deadline nears
- US existing home sales hit 7-month high; affordability remains a challenge
- Fed minions working on a new scheme for setting U.S. interest rates:
- Bigger stimulus developing in China:
- BOJ minions get mixed economic data to cloud their plan to hike Japan’s interest rates:
- Japan’s core inflation accelerates in September, stays above BOJ target
- Japan’s factory activity hits 19-month-low in October, PMI shows
- Wall Street ended higher as Trump–Xi meeting was confirmed
- Friday, 24 October 2025
-
- Signs and portents for the U.S. economy:
- Oil climbs for second day on supply fears due to US sanctions on Russian companies
- Fed minions expected to deliver rate cut next week, thinking about undoing excessive regulation on banks:
- Fed to hand banks a win with proposed ‘stress test’ overhaul
- Bigger trouble, stimulus developing in China:
- Growth signs developing in Eurozone:
- Wall Street notches record close after soft CPI data, posts best week since early August
The Atlanta Fed’s GDPNow tool projection of real GDP growth in the U.S. during the recently ended 2025-Q3 remained unchanged at +3.8% with data reports on hold because of the Senate Democrats’ ongoing refusal to fund government operations. The BEA’s official estimates of GDP will be on hold as well.
Image credit: Microsoft Copilot Designer. Prompt: “An editorial cartoon of a Wall Street bull who is happy with a lower-than-expected inflation report and upcoming trade talks between U.S. President Trump and China’s Chairman Xi”, followed by a second prompt: “Add another speech bubble that says “No wonder the S&P 500 set a new record high!”
Source: https://politicalcalculations.blogspot.com/2025/10/lower-than-expected-inflation-and.html
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.



